Indication
Immunosuppression-related Infectious Disease
1 clinical trial
1 product
Clinical trial
A Prospective Multicenter Open-label, Not Controlled Phase Ib-II Clinical Trial to Assess the Safety and Immunologic Efficacy of Virus-specific T Lymphocytes From the Best Donor in Receptors of Hematopoietic Progenitor Allogeneic TransplantStatus: Completed, Estimated PCD: 2021-10-18
Product
Activated T-Lymphocytes